Research
Hormonal
GLP-1 receptor agonists treat type-2 diabetes and obesity by mimicking the endogenous hormone GLP-1, which stimulates glucose-dependent insulin secretion, slows gastric emptying, and inhibits food intake.
GLP-1 receptor agonists are effective, FDA-approved treatments for type-2 diabetes and obesity. They work by mimicking a natural gut hormone to increase insulin, slow digestion, and reduce appetite. Consult a doctor to see if a GLP-1 based medication is appropriate for your health profile.
StrongSupportsVERY_HIGH confidence
Biochemically modified for enhanced potency and sustained action, GLP-1 receptor agonists are successfully in clinical use for the treatment of type-2 diabetes, and several GLP-1-based pharmacotherapies are in clinical evaluation for the treatment of obesity.
Why this rating
The paper is a comprehensive review by leading experts confirming clinical use and broad metabolic effects.
Source
Glucagon-like peptide 1 (GLP-1)
Timo D. Müller et al. · Molecular Metabolism · 2019
DOI 10.1016/j.molmet.2019.09.010
narrative_reviewCited 1,709×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →